Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)—Polish compassionate use experience

Recent developments in the field of targeted therapy have led to the discovery of a new drug, plerixafor, that is a specific inhibitor of the CXCR4 receptor. Plerixafor acts in concert with granulocyte colony-stimulating factor (G-CSF) to increase the number of stem cells circulating in the peripher...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Basak, Grzegorz Wladyslaw, Knopinska-Posluszny, Wanda, Matuszak, Magdalena, Kisiel, Elzbieta, Hawrylecka, Dorota, Szmigielska-Kaplon, Anna, Urbaniak-Kujda, Donata, Dybko, Jaroslaw, Zielinska, Patrycja, Dabrowska-Iwanicka, Anna, Werkun, Joanna, Rzepecki, Piotr, Wroblewska, Wiktoria, Wiktor-Jedrzejczak, Wieslaw
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer-Verlag 2010
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3070880/
https://ncbi.nlm.nih.gov/pubmed/20938660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-010-1098-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller